Andrew Gilchrist appointed as non-executive director at PLC

Feb.09.2023
Andrew Gilchrist appointed as non-executive director at PLC
Andrew Gilchrist appointed as non-executive director of Imperial Brands, effective from March 1st, 2023.

On February 7th, Imperial Tobacco (PLC) announced that Andrew Gilchrist will join the PLC Board of Directors as a non-executive director, effective from March 1st, 2023.


Andrew previously served as the Chief Financial Officer of Renault USA until it was acquired by British American Tobacco (BAT) in 2017. He has over 20 years of operations and financial experience in the tobacco industry. At Renault, Andrew held a series of leadership positions, including Chief Information Officer, Chief Business Officer, and Business Development Director. Early in his career, he worked in marketing and planning roles at BAT.


Chair Thérèse Esperdy said, "I am pleased to welcome Andrew to the board. In addition to his combined expertise in business and finance in our industry, he also has a strong track record in business development, strategic planning, and business integration. These skills, along with our continued transformation of Imperial Brands, will further enhance the efficiency of the board.


From March 1, 2023, Andrew will also join the Audit Committee and the Personnel and Governance Committee.


Reference(s):


【1】Appointment to the Board of Directors.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.
Mar.19 by 2FIRSTS.ai
KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
According to a Korean media report, KT&G is developing a smokeless nicotine product that delivers nicotine through oral absorption and is preparing a pilot production line for research and development.
Apr.08 by 2FIRSTS.ai
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem US, the maker and seller of Zone nicotine pouches, has voluntarily dismissed its lawsuit against the U.S. Food and Drug Administration, which it had accused of unfairly delaying its market application.
Mar.25 by 2FIRSTS.ai
Brazilian Police Find More Than 40,000 E-Cigarettes in Truck With Hidden Safe
Brazilian Police Find More Than 40,000 E-Cigarettes in Truck With Hidden Safe
Military police in Brazil’s Paraná state found more than 40,000 e-cigarettes inside a truck with a hidden safe on April 8 in Campina Grande do Sul, in the Curitiba metropolitan area.
Apr.13 by 2FIRSTS.ai
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai
Indonesian Health Ministry Says New Vape Rules Will Cover Age Limits, Advertising, and Product Standards
Indonesian Health Ministry Says New Vape Rules Will Cover Age Limits, Advertising, and Product Standards
Indonesia’s Ministry of Health is preparing to implement regulations on electronic cigarettes, as provided for in Government Regulation No. 28 of 2024. The ministry said e-cigarettes will be regulated under provisions equivalent to those applied to conventional cigarettes, including age restrictions, advertising controls, product content standards, pictorial health warnings, and bans on use in smoke-free areas.
Apr.16 by 2FIRSTS.ai